Please use this identifier to cite or link to this item: doi:10.22028/D291-44369
Title: Regulation of ADAM10 activity through microdomain-dependent intracellular calcium changes
Author(s): Gharzia, Federico Guillermo
Aljohmani, Ahmad
Beck, Andreas
Philipp, Andreas
Yildiz, Daniela
Language: English
Title: Cell Communication and Signaling
Volume: 22
Issue: 1
Publisher/Platform: BMC
Year of Publication: 2024
Free key words: Calcium
Proteolysis
Metalloproteinases
Exosomes
Transient receptor potential channels
Junction and adhesion molecules
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: A disintegrin and metalloproteinases (ADAMs) are transmembrane proteases that cleave other proteins close to the surface in a process called shedding. The prominent member ADAM10 has been linked to several pathologies such as Alzheimer’s disease, bacterial infection, cancer development and metastasis. Although the regulation of the ADAM10 activity by calcium influx and calmodulin inhibition has been reported, the spatiotemporal regulation of Ca2+-dependent ADAM10 activation and the required source of Ca2+ ions have not been thoroughly studied. In the present study, we observed the rapid Ca2+-dependent activation of ADAM10 in A549 lung carcinoma cells upon stimulation with ionomycin. The calmodulin-inhibitors trifluoperazine and ophiobolin A mediated delayed activation of ADAM10, which apparently did not depend on intracellular Ca2+ in the case of trifluoperazine. Furthermore, the surface translocation and release of ADAM10 in extracellular vesicles exhibited different kinetics and were only partially linked to catalytic activation. Finally, ADAM10 activation was observed after the entry of Ca2+ through certain channels, such as canonical members of transient receptor potential (TRP) channels. Therefore, the opening of particular channels for Ca2+ entry points and subsequent Ca2+ flux as well as the temporal aspects of the consequent increase in Ca2+ levels, must be considered for future therapeutic options involving the increasing or decreasing ADAM10 activity.
DOI of the first publication: 10.1186/s12964-024-01891-5
URL of the first publication: https://biosignaling.biomedcentral.com/articles/10.1186/s12964-024-01891-5
Link to this record: urn:nbn:de:bsz:291--ds-443691
hdl:20.500.11880/39641
http://dx.doi.org/10.22028/D291-44369
ISSN: 1478-811X
Date of registration: 13-Feb-2025
Description of the related object: Supplementary Information
Related object: https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-024-01891-5/MediaObjects/12964_2024_1891_MOESM1_ESM.jpg
https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-024-01891-5/MediaObjects/12964_2024_1891_MOESM2_ESM.jpg
https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-024-01891-5/MediaObjects/12964_2024_1891_MOESM3_ESM.jpg
https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-024-01891-5/MediaObjects/12964_2024_1891_MOESM4_ESM.jpg
https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-024-01891-5/MediaObjects/12964_2024_1891_MOESM5_ESM.jpg
https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-024-01891-5/MediaObjects/12964_2024_1891_MOESM6_ESM.jpg
https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-024-01891-5/MediaObjects/12964_2024_1891_MOESM7_ESM.jpg
https://static-content.springer.com/esm/art%3A10.1186%2Fs12964-024-01891-5/MediaObjects/12964_2024_1891_MOESM8_ESM.jpg
Faculty: M - Medizinische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
Professorship: M - Jun.-Prof. Dr. Daniela Yildiz
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
s12964-024-01891-5.pdf8,05 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons